mycophenolate mofetil


Also found in: Medical, Acronyms, Wikipedia.
Translations

mycophenolate mofetil

n micofenolato de mofetilo
References in periodicals archive ?
Contract notice: supply of medicines levetiracetam, lamivudine, mycophenolate mofetil and mycophenolic acid for all osakidetza service organizations
Cyclophosphamide, chlorambucil, intravenous tacrolimus, mycophenolate mofetil and thalidomide have also been found to be effective in a limited number of patients refractory to other therapies.
Her immunosuppression regimen used was prednisone and mycophenolate mofetil.
AURORA is a 52-week global double-blind placebo controlled study, designed to demonstrate that voclosporin added to the current standard of care of mycophenolate mofetil can increase overall renal response rates in the presence of extremely low steroids.
7mg voclosporin BID and mycophenolate mofetil (MMF) or MMF and placebo, with both groups receiving a stringent oral corticosteroid taper.
Refractory patients received a wide range of systemic agents--most commonly chloroquine (Aralen) and mycophenolate mofetil (Cellcept), followed by quinacrine, dapsone, methotrexate, belimumab (Benlysta), azathioprine, thalidomide (Thalomid), lenalidomide (Revlimid), prednisone, and rituximab (Rituxan), Ms.
Based on available evidence, azathioprine and mycophenolate mofetil are the drugs of first choice.
Salinas needs P54,990 for his medicines: Tacrolimus six times a day at P1,320; Mycophenolate mofetil, four times a day at P508, and Amlodipine once a day at P5.
Mycophenolate mofetil (MMF), an immunosuppressive agent currently used in transplantology, can also be used as one of the therapeutic options in steroid dependent (SD), steroid resistant (SR), and frequently relapsing (FR) nephrotic syndrome in children [1-4].
Mycophenolate mofetil (MMF) is an immunosuppressive drug used in solid organ transplant patients and had been reported to be associated with pulmonary fibrosis and organizing pneumonia with no other forms of histopathologic abnormalities documented in the English literature.
Northbrook, IL, announced this week that ASTAGRAF XL for the prophylaxis of organ rejection in patients receiving a kidney transplant used with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction, is now available in US pharmacies nationwide.
Ophthalmologists and eye specialists from the US and Europe focus on recent innovative treatment options, but begin with an outline of treatment principles and the most conventional treatments, including corticosteroids and other immunosuppresant agents, then discuss the newer available agents for intraocular inflammation, such as drugs adopted from rheumatology, mycophenolate mofetil, anti-tumor necrosis factor-alpha agents, anti-interleuken therapy, interferon-alpha therapy, rituximab, intravitreal injection therapy, corticosteroid intravitreal implants, and calcineurin inhibitor voclosporin, mammalian target of rapamycin inhibitor sirolumus, and the IL-1 trap rilonacept.